|
Fibrinolysis
Citations 1-10 of 140 total displayed.
|
Most recent content
(23 Jun 2009):
|
- Interventional Cardiology
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
- Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation 119: 3101 -3109; published online before print as doi:10.1161/CIRCULATIONAHA.108.793745
[Abstract]
[Full text]
|
Past content
(since Jan 1999):
|
- Articles
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction. Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
- Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation published June 8, 2009, doi:10.1161/CIRCULATIONAHA.108.793745
[Abstract]
- Hypertension
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
- Chiara Giannarelli, Agostino Virdis, Ferdinando De Negri, Armando Magagna, Emiliano Duranti, Antonio Salvetti, and Stefano Taddei
Circulation 119: 1625 -1633; published online before print as doi:10.1161/CIRCULATIONAHA.108.782482
[Abstract]
[Full text]
- Articles
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
- Chiara Giannarelli, Agostino Virdis, Ferdinando De Negri, Armando Magagna, Emiliano Duranti, Antonio Salvetti, and Stefano Taddei
Circulation published March 16, 2009, doi:10.1161/CIRCULATIONAHA.108.782482
[Abstract]
- Controversies in Cardiovascular Medicine
Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
- Paul W. Armstrong, Cynthia M. Westerhout, and Robert C. Welsh
Circulation 2009; 119: 1293-1303, doi:10.1161/CIRCULATIONAHA.108.796383
[Full text]
- Controversies in Cardiovascular Medicine
Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
- Peter Bogaty
Circulation 2009; 119: 1304-1310, doi:10.1161/CIRCULATIONAHA.107.750679
[Full text]
- Coronary Heart Disease
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
- Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation 118: 2783 -2789; published online before print as doi:10.1161/CIRCULATIONAHA.108.776690
[Abstract]
[Full text]
- Articles
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
- Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation published December 8, 2008, doi:10.1161/CIRCULATIONAHA.108.776690
[Abstract]
- Images in Cardiovascular Medicine
Regression of Thrombus and Electrocardiographic Changes With Thrombolytic Therapy in Acute Massive Pulmonary Embolism
- Evin Bozcali and Yildiray Tutpinar
Circulation 2008; 118: 2207-2208, doi:10.1161/CIRCULATIONAHA.108.780601
[Full text]
- Editorials
A Novel Role for Tissue-Type Plasminogen Activator: Prevention of Thromboembolic Occlusion
- David J. Schneider and Burton E. Sobel
Circulation 2008; 118: 1408-1409, doi:10.1161/CIRCULATIONAHA.108.807586
[Full text]
|
|
